Gene · 4131
Papers2,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Potential Key Genes and Prognostic Biomarkers of Lung Cancer Based on Bioinformatics. | Biomed Res Int | 2023 | 36714024 | PubTator, text mining | PubMed |
| A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer. | BMC Urol | 2023 | 36709279 | PubTator, text mining | PubMed |
| Digital color-coded molecular barcoding reveals dysregulation of common FUS and FMRP targets in soma and neurites of ALS mutant motoneurons. | Cell Death Discov | 2023 | 36702823 | PubTator, text mining | PubMed |
| FMRP activity and control of Csw/SHP2 translation regulate MAPK-dependent synaptic transmission. | PLoS Biol | 2023 | 36701299 | PubTator, text mining | PubMed |
| 3'UTR Diversity: Expanding Repertoire of RNA Alterations in Human mRNAs. | Mol Cells | 2023 | 36697237 | PubTator, text mining | PubMed |
| Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | J Biol Chem | 2023 | 36634849 | PubTator, text mining | PubMed |
| AMPAR autoimmunity: Neurological and oncological accompaniments and co-existing neural autoantibodies. | J Neuroimmunol | 2023 | 36608398 | PubTator, text mining | PubMed |
| Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. | Cancer Cell | 2023 | 36563681 | PubTator, text mining | PubMed |
| High expression of COL6A1 predicts poor prognosis and response to immunotherapy in bladder cancer. | Cell Cycle | 2023 | 36474424 | PubTator, text mining | PubMed |
| Tubulin Cytoskeleton in Neurodegenerative Diseases-not Only Primary Tubulinopathies. | Cell Mol Neurobiol | 2023 | 36352320 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| The Fragile X Messenger Ribonucleoprotein 1 Participates in Axon Guidance Mediated by the Wnt/Planar Cell Polarity Pathway. | Neuroscience | 2023 | 36191829 | PubTator, text mining | PubMed |
| CRISPR/Cas9 screen in human iPSC-derived cortical neurons identifies NEK6 as a novel disease modifier of C9orf72 poly(PR) toxicity. | Alzheimers Dement | 2023 | 35993441 | PubTator, text mining | PubMed |
| Microtubule affinity regulating kinase (MARK/Par1) isoforms differentially regulate Alzheimer-like TAU missorting and Aβ-mediated synapse pathology. | Neural Regen Res | 2023 | 35900423 | PubTator, text mining | PubMed |
| Deficiency of Parkinson's Related Protein DJ-1 Alters Cdk5 Signalling and Induces Neuronal Death by Aberrant Cell Cycle Re-entry. | Cell Mol Neurobiol | 2023 | 35182267 | PubTator, text mining | PubMed |
| Dysregulated Protein Phosphorylation as Main Contributor of Granulovacuolar Degeneration at the First Stages of Neurofibrillary Tangles Pathology. | Neuroscience | 2023 | 34757172 | PubTator, text mining | PubMed |
| MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. | Cell Biol Toxicol | 2023 | 34581912 | PubTator, text mining | PubMed |
| Protein phosphorylation: A potential target in glioma development. | Ibrain | 2022 | 37786890 | PubTator, text mining | PubMed |
| Early and late genome-wide gastric epithelial transcriptome response during infection with the human carcinogen Helicobacterpylori. | Cell Insight | 2022 | 37193047 | PubTator, text mining | PubMed |
| Effect of High dose Gonadotropin Stimulation on Follicular Atresia through Light Chain 3B and Voltage Dependent Anion Channel 2. | J Hum Reprod Sci | 2022 | 37033140 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4131/papers?page=11